NEW YORK (GenomeWeb News) – GeneGo will use gene expression data from Entelos to develop its predictive toxicology modeling technology, GeneGo said.

Under the license agreement, GeneGo will use Entelos' DrugMatrix gene expression data to further develop its Functional Descriptor models.

Richard Brennan, GeneGo's director of toxicology, said that access to "a comprehensive, pharmacologically diverse and fully annotated compendium of gene expression data is critical to developing high-performance predictive models."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.